KORU Medical Systems Inc. (KRMD) Reports Q3 Loss, Tops Revenue Estimates

Financial Performance - KORU Medical Systems Inc. reported a quarterly loss of $0.03 per share, consistent with the Zacks Consensus Estimate, compared to a loss of $0.03 per share a year ago [1] - The company posted revenues of $8.18 million for the quarter ended September 2024, exceeding the Zacks Consensus Estimate by 6.86%, and up from $7 million in the same quarter last year [2] - Over the last four quarters, KORU Medical has surpassed consensus EPS estimates three times and topped consensus revenue estimates four times [2][3] Stock Performance - KORU Medical shares have increased by approximately 21% since the beginning of the year, while the S&P 500 has gained 25.5% [3] - The current Zacks Rank for KORU Medical is 3 (Hold), indicating that the shares are expected to perform in line with the market in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is -$0.04 on revenues of $8.01 million, and for the current fiscal year, it is -$0.13 on revenues of $32.28 million [7] - The estimate revisions trend for KORU Medical is mixed, and future earnings expectations will depend on management's commentary during the earnings call [3][4] Industry Context - The Medical - Instruments industry, to which KORU Medical belongs, is currently ranked in the top 26% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8]